We found that silencing MyoD1 could inhibit the formation of kidney stones by downregulating PINK1 expression in both in vitro and in vivo kidney stone models, providing new insights into the pathogenesis of pediatric nephrolithiasis. Here, PINK1 is linked to nephrolithiasis.